Statements (35)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
sedative
antihistamine over-the-counter medication |
| gptkbp:ATCCode |
R06AA09
|
| gptkbp:brand |
gptkb:NyQuil
gptkb:Unisom |
| gptkbp:CASNumber |
562-10-7
|
| gptkbp:chemicalFormula |
C17H22N2O
|
| gptkbp:contraindication |
glaucoma
urinary retention severe liver disease |
| gptkbp:discoveredBy |
gptkb:Bayer
|
| gptkbp:drugClass |
ethanolamine
first-generation antihistamine |
| gptkbp:eliminationHalfLife |
10 hours
|
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
doxylamine succinate
|
| gptkbp:introducedIn |
1948
|
| gptkbp:legalStatus |
OTC (United States)
|
| gptkbp:mechanismOfAction |
histamine H1 receptor antagonist
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
A (Australia)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
drowsiness dry mouth urinary retention |
| gptkbp:usedFor |
treatment of insomnia
relief of cold symptoms relief of allergy symptoms |
| gptkbp:bfsParent |
gptkb:NyQuil
gptkb:Vicks_44 gptkb:Vicks_NyQuil gptkb:Unisom |
| gptkbp:bfsLayer |
7
|